home / stock / aplt / aplt news


APLT News and Press, Applied Therapeutics Inc. From 12/15/20

Stock Information

Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NASDAQ
Website: appliedtherapeutics.com

Menu

APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...

APLT - Applied Therapeutics to be Added to NASDAQ Biotechnology Index

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company wa...

APLT - Applied Therapeutics Announces Launch of Galactosemia Awareness and Education Initiative

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the launch of Gal...

APLT - Applied Therapeutics Announces MRS Data from ACTION-Galactosemia Study

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced magnetic resonance ...

APLT - Akers Biosciences, Cidara Therapeutics leads healthcare gainers; Applied Therapeutics, Soliton among major losers

Gainers: Akers Biosciences (AKER) +45%, Cidara Therapeutics (CDTX) +29%, Five Prime Therapeutics (FPRX) +24%, Zhongchao (ZCMD) +22%, Vaxart (VXRT) +22%.Losers: Applied Therapeutics (APLT) -12%, Soliton (SOLY) -13%, Harmony ...

APLT - Applied Therapeutics EPS misses by $0.21

Applied Therapeutics (APLT): Q3 GAAP EPS of -$1.33 misses by $0.21.Cash, equivalents and short-term investments totaled $116.5M.Shares +1.03% PM.Press Release For further details see: Applied Therapeutics EPS misses by $0.21

APLT - Applied Therapeutics Reports Third Quarter 2020 Financial Results

Continued enrollment in the ARISE-HF Phase 3 global registrational study of AT-001 in Diabetic Cardiomyopathy (fatal heart disease affecting ~17% diabetics) On track to initiate rare disease franchise expansion programs in SORD Deficiency and PMM2-CDG studies in the first half o...

APLT - Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at the American Heart Association (AHA) Scientific Sessions 2020

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today  presentation ...

APLT - Miragen Therapeutics, Titan Pharmaceuticals leads healthcare gainers; Neovasc, Akerna among major losers

Gainers: Miragen Therapeutics (MGEN) +86%, Titan Pharmaceuticals (TTNP) +62%, Community Health Systems (CYH) +35%, Scholar Rock Holding (SRRK) +7%, Rafael Holdings (RFL) +7%.Losers: Neovasc (NVCN) -44%, Akerna (KERN) -19%, Tiziana Li...

APLT - SRRK, SYNL, KTCC and SUM among after-hours movers

Gainers: [[SRRK]] +23.7%. [[SYNL]] +12.3%. [[CYH]] +11.6%. [[FSLR]] +8.8%. [[MSTR]] +7.1%.Losers: [[KTCC]] -12.8%. [[SUM]] -8.7%. [[RCUS]] -8.3%. [[BGFV]] -6.0%. [[APLT]] -5.8%. For further details see: SRRK, SYNL, KTCC and SUM among after-hours movers

APLT - Avoid These 4 DOWNGRADED Stocks

The stock market is undergoing some distribution. During these periods of time, stock selection is even more important. The POWR Ratings can help you identify ones that are performing well and avoid those with poor prospects. Here are five stocks the POWR Ratings have recently downgraded. ...

Previous 10 Next 10